Please select an option below to help us tailor your newsletter to best suit your content interests!
Through research and partnerships across the oncology community, we are committed to closing the gap in existing disparities in cancer care. A new study in partnership with Dr. Gregory Vidal and our West family, OneOncology, Genentech, and Flatiron Health examined elements of inequity in next generation sequencing (NGS) for patients with advanced non-small cell lung… Read more »
MEET AMY: SURVIVOR OF METASTATIC MELANOMA OF THE LUNGS & BRAIN What a warrior! Amy’s cancer journey has been a wild ride – but her optimism, perseverance, and drive to advocate for her own health (and others) has been her motivation! Amy shares details of her personal battle with cancer in the video below, and… Read more »
Dr. Jason Porter has partnered with OncLive to present a Lung Cancer State of the Science Summit! Academic & community-based physicians along with healthcare professionals are invited to attend this meeting on Thursday, May 11 in Nashville, TN. Attendees will expand their knowledge of novel treatment approaches and applying state-of-the-art treatment strategies. Click the link below to register… Read more »
IS YOUR NEW YEARS RESOLUTION TO QUIT SMOKING? Patients are encouraged to join our *free* smoking cessation workshops in January, February, or March at our Wolf River campus. With a total of 9 session options, patients will receive free tips, support, and information on pharmaceutical options to help quit smoking. No registration is necessary. For… Read more »
Our West Family is excited to launch a lung screening program at several of our campuses across the MidSouth! Patients and referring providers can schedule an appointment to receive a low-dose CT scan to detect lung cancer early. We accept all major insurance carriers and patients must meet the following criteria: – Between the ages of… Read more »
Our team of 48 Medical Oncology & Hematology providers collaborate with highly specialized oncology experts to evaluate new research options and individual treatment plans. At West Cancer Center & Research Institute we offer the most comprehensive approach to cancer care. Our medical oncologists work closely with oncology surgeons, radiation oncologists, clinical researchers, radiologists, pathologists, genetic... Read more »
Click here to view this full article on OncLive.com. The addition of immune checkpoint inhibitors to chemotherapy has led to durable responses and improved survival without increased toxicity in patients with small cell lung cancer (SCLC), according to David C. Portnoy, MD, FACP, who added that biomarkers of response to this approach and a… Read more »
The 6th Annual West Oncology Conference will serve as a valuable forum for the presentation and discussion of new research findings. Participants will be provided with an update on practice-changing data on women’s cancers, genitourinary malignancies, disparities in cancer care, gastrointestinal cancers, hematological malignancies, and lung cancer in a practical and interactive format, fostering discussion… Read more »
Matthew Stein, MD (Hematology/Oncology) Presenting at: IASLC (Int’l Assoc. for the Study of Lung Cancer) Yokohama, Japan-October 16, 2017 Abstract 10429 JAK Pseudokinase Domain Variants Highlight nRTK nsSNPs Identified with Next-Generation Sequencing in NSCLC Patients Type: Peer Review Topic: 02. Biology/Pathology Authors: Matthew K. Stein, Lindsay K. Morris, Mike G. Martin; West Cancer Center, University… Read more »